Ceporex Vet 50 mg Tablet for Cats and Dogs

Pays: Royaume-Uni

Langue: anglais

Source: VMD (Veterinary Medicines Directorate)

Ingrédients actifs:

Cefalexin

Disponible depuis:

Schering-Plough Ltd

DCI (Dénomination commune internationale):

Cefalexin

Statut de autorisation:

Expired

Résumé des caractéristiques du produit

Revised: 14 May 2008
AN: 00870/2007
1.
NAME OF VETERINARY MEDICINAL PRODUCT
Ceporex Vet 50mg Tablet for cats and dogs
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Active constituents:
mg/tablet
Cefalexin
50.0
Other excipients:
Opadry Pink OY-S-6927
1.0

Titanium Dioxide (E171)
0.30

Erythrosine Lake (E127)
0.03

Indigo Carmine (E132)
0.0007
For a full list of excipients, see section 6.1
3.
PHARMACEUTICAL FORM
Film-coated tablet.
Round, convex, pink film coated tablets.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Cats and dogs
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
The tablets are indicated for oral antibiotic therapy in cats and
dogs. Cefalexin is
a broad spectrum cephalosporin antibiotic with bactericidal activity
against a wide
range of Gram-positive and Gram-negative bacteria.
The following micro-organisms have been shown to be sensitive to
Cefalexin _in _
_vitro: Staphylococcus _spp (including penicillin-resistant strains),
_Streptococcus _
spp, _Corynebacterium _spp, _Pasteurella multocida_, _Escherichia
coli_, _Micrococcus _
spp, _Moraxella _spp.
When susceptible organisms are present, the product may be effective
in the
treatment of infections of the respiratory tract, urogenital tract,
the skin and
localised infections in soft tissue.
In dogs it may also be effective in the treatment of infections of the
gastro-
intestinal tract.
Revised: 14 May 2008
AN: 00870/2007
4.3
CONTRA-INDICATIONS
Hypersensitivity to Cefalexin is very rare, however, the product
should not be
administered to animals which are known to be hypersensitive to
Cefalexin.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
As with other antibiotics which are excreted mainly by the kidneys,
unnecessary
accumulation may occur in the body when renal function is impaired. In
cases of
known renal insufficiency the dose should be reduced.
4.5
SPECIAL PRECAUTIONS FOR USE
_SPECIAL PRECAUTIONS FOR USE IN ANIMALS_
None
_SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE
PRODUCT_ _TO_
_THE ANIMAL_
Cefalosporins may ca